Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
about
The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphomaComparison of a CHOP-LAsp-based protocol with and without maintenance for canine multicentric lymphoma.Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218DNA sequence variants in the carbonyl reductase 1 (cbr1) gene in seven breeds of Canis lupus familiaris.Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).Detection of retinoid receptors in non-neoplastic canine lymph nodes and in lymphoma.The dog as a possible animal model for human non-Hodgkin lymphoma: a review.Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.Canine lymphoma: a review.Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature.Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.Criteria for designation of clinical substage in canine lymphoma: a survey of veterinary oncologists.Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy.Detection of clonal antigen receptor gene rearrangement in dogs with lymphoma by real-time polymerase chain reaction and melting curve analysis.Prognostic value of baseline absolute lymphocyte concentration and neutrophil/lymphocyte ratio in dogs with newly diagnosed multi-centric lymphoma.Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma.Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma.CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.Diagnostic evaluation and treatment recommendations for dogs with substage-a high-grade multicentric lymphoma: results of a survey of veterinarians.Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.Clinical presentation, treatment and outcome in 31 dogs with presumed primary colorectal lymphoma (2001-2013).Nucleated erythrocytes in blood smears of dogs undergoing chemotherapy.
P2860
Q33413087-CE7C7F79-7E9D-414B-9E09-829E37DD9AB6Q33438551-8C66654D-C50C-45DE-970E-FC0B3BA30327Q33688244-69FFEA16-A4B6-45DE-9A87-A8AD507CF666Q35745257-DDBA0F14-ECBA-4F5D-9E94-AB195136DF76Q36012238-AF417DBF-7917-48F6-A63A-5BAEC80D6E28Q37234338-ECEC3B6D-1D88-4D5F-B2E1-BDB2CA3B311EQ37400745-9347A171-1ED1-4766-B11D-BF6EDD60775AQ38016826-F0E2079D-87DC-4D2D-9895-6DAA81D51B5BQ38647190-6E18F0BE-9FCB-43EC-81F4-87DDFF7D1916Q38765145-3EE3CAEA-CC56-4C56-87A5-B5223820C8D4Q38842189-17949DF2-02DC-405C-83FE-62389036878AQ39248797-1C1AC89D-DB94-4CC0-B0CF-37572CEB8F15Q39504944-066D07D0-F8A5-49B8-8B28-DF2F15AAF871Q39593967-968314D1-7DD6-4AD3-9AE5-247B0829203FQ41895653-003BA6C1-F7AA-4542-B239-F8881A028D39Q44073545-172651A0-BED1-415E-9ED4-6CECFFF926D4Q45641138-C6B49286-9216-497D-A162-0274421BE8F3Q45986875-099BB882-1E64-4281-8F5D-5E7CD2C486FEQ46174483-1319B159-8F73-4F25-89C2-F71E09B9D6B2Q46379121-3779CA82-3C44-4DEA-99DC-7A2F13841D7CQ46807325-012519B4-D710-43BF-9931-71A41FD1E339Q46807327-DC346B15-0854-4846-98D4-C95626D53AF0Q51057180-29B4C7A6-6424-440D-814A-8873C782A737Q53135043-1A8A5F2E-4B0B-4A6D-B696-2D0A55A88ED5Q53455293-4983D9F1-FB0B-47B1-938E-B218940CF831
P2860
Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@ast
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@en
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@nl
type
label
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@ast
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@en
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@nl
prefLabel
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@ast
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@en
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@nl
P2093
P1476
Treatment of dogs with lymphom ...... ination chemotherapy protocol.
@en
P2093
P304
P356
10.1111/J.1939-1676.2006.TB01810.X
P577
2006-07-01T00:00:00Z